|
|
|
Our Oncology programs seek to increase quality and patient safety by increasing compliance with evidence-based standards of care.
Our programs include:
-
Erythropoietin (EPO) Drug Policy
-
Herceptin Drug Policy/HER2 Testing (Human Epidermal Growth Factor Receptor 2)
-
UnitedHealthcare Premium® Designation Program for Oncology
-
UnitedHealthcare's Cancer Support Program
|
|
|
